BlackRock Amends CVS Health Stake, Signals Portfolio Shift

TL;DR

**BlackRock updated its CVS Health ownership, signaling a potential shift in its investment.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in their ownership of CVS Health Corp. common stock as of December 31, 2023. This filing, Amendment No. 11, updates their previous disclosures regarding their stake in the retail-drug store giant. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal shifts in their confidence or investment strategy regarding CVS Health, potentially influencing other investors.

Why It Matters

Changes in major institutional holdings like BlackRock's can influence market sentiment and potentially impact CVS Health's stock price, as large investors often move significant capital.

Risk Assessment

Risk Level: low — This filing is a routine update from a large institutional investor and doesn't inherently signal high risk, but rather a change in ownership percentage.

Analyst Insight

An investor should monitor subsequent filings from BlackRock or other major institutions to understand the magnitude and direction of any changes in their CVS Health holdings, as this filing only indicates an amendment, not the specific change in percentage.

Key Players & Entities

• BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
• CVS HEALTH Corp (company) — the subject company whose shares are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 26, 2024 (date) — the filing date of the SC 13G/A
• Amendment No. 11 (number) — the specific amendment number of the filing

FAQ

From the Filing

0001086364-24-004861.txt : 20240126 0001086364-24-004861.hdr.sgml : 20240126 20240126172522 ACCESSION NUMBER: 0001086364-24-004861 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-30930 FILM NUMBER: 24569148 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us1266501006_012624.txt us1266501006_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) CVS HEALTH CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 126650100 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 126650100 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 78025316 (6) Shared voting power 0 (7) Sole dispositive power 87020610 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 87020610 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 6.8% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- CVS HEALTH CORPORATION Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- ONE CVS DR